Annovis Bio is up 14.0%, or $1.08 to $8.85.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
- Largest borrow rate increases among liquid names
- Annovis Bio initiated with a Buy at EF Hutton
- Annovis Bio announces preclinical data on buntanetap with GLP-1 agonist
- Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist